Shenfu injection: a review of pharmacological effects on cardiovascular diseases
- PMID: 38420190
- PMCID: PMC10899515
- DOI: 10.3389/fphar.2024.1279584
Shenfu injection: a review of pharmacological effects on cardiovascular diseases
Abstract
Shenfu injection (SFI), composed of ginseng and aconite, is a Chinese patent developed from the classic traditional prescription Shenfu Decoction created more than 700 years ago. SFI has been widely used in China for over 30 years for treating cardiovascular diseases. The main components in it include ginsenosides and aconitum alkaloids. In recent years, the role of SFI in the treatment of cardiovascular diseases has attracted much attention. The pharmacological effects and therapeutic applications of SFI in cardiovascular diseases are summarized here, highlighting pharmacological features and potential mechanisms developments, confirming that SFI can play a role in multiple ways and is a promising drug for treating cardiovascular diseases.
Keywords: Shenfu injection; TCM (traditional Chinese medicine); cardiovascular disease; clinical trial; heart failure; pharmacology.
Copyright © 2024 Xu, Xie, Hu, Tong and Peng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
